Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DOUGLAS NAVERSEN

NPI
1568405496
CMS profile
70141
Location
MEDFORD, OR

General Payments · PY2018–2024

$3,491.33

  • Reported across 160 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$787.79

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $715.79 37
Education $72.00 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $276.93 15
Janssen Biotech, Inc. $161.21 8
Regeneron Healthcare Solutions, Inc. $121.84 4
Lilly USA, LLC $92.71 5
GENZYME CORPORATION $49.74 2
UCB, Inc. $37.32 1
Arcutis Biotherapeutics, Inc. $29.11 2
Galderma Laboratories, L.P. $18.93 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $328.03 16
PY2019 $418.94 13
PY2020 $108.71 6
PY2021 $181.77 2
PY2022 $822.15 36
PY2023 $843.94 49
PY2024 $787.79 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $10.70 01/04/2024 Food and Beverage Undisputed 01/23/2026 1105104860 CMS
ABBVIE INC. $15.51 01/18/2024 Food and Beverage Undisputed 01/23/2026 1105104862 CMS
ABBVIE INC. $18.15 02/06/2024 Food and Beverage Undisputed 01/23/2026 1105104864 CMS
ABBVIE INC. $2.96 02/20/2024 Food and Beverage Undisputed 01/23/2026 1105104866 CMS
ABBVIE INC. $11.13 02/27/2024 Food and Beverage Undisputed 01/23/2026 1105104868 CMS
ABBVIE INC. $20.34 03/05/2024 Food and Beverage Undisputed 01/23/2026 1105104870 CMS
ABBVIE INC. $20.08 04/01/2024 Food and Beverage Undisputed 01/23/2026 1105104872 CMS
ABBVIE INC. $18.84 04/24/2024 Food and Beverage Undisputed 01/23/2026 1105104874 CMS
ABBVIE INC. $20.44 05/15/2024 Food and Beverage Undisputed 01/23/2026 1105104876 CMS
ABBVIE INC. $22.55 05/29/2024 Food and Beverage Undisputed 01/23/2026 1105104878 CMS
ABBVIE INC. $19.57 07/23/2024 Food and Beverage Undisputed 01/23/2026 1105104880 CMS
ABBVIE INC. $20.21 08/20/2024 Food and Beverage Undisputed 01/23/2026 1105104882 CMS
ABBVIE INC. $22.17 10/15/2024 Food and Beverage Undisputed 01/23/2026 1105104884 CMS
ABBVIE INC. $19.93 11/12/2024 Food and Beverage Undisputed 01/23/2026 1105104886 CMS
ABBVIE INC. $34.35 11/18/2024 Food and Beverage Undisputed 01/23/2026 1105104888 CMS
Arcutis Biotherapeutics, Inc. $15.87 04/11/2024 Food and Beverage Undisputed 01/23/2026 1121044611 CMS
Arcutis Biotherapeutics, Inc. $13.24 07/17/2024 Food and Beverage Undisputed 01/23/2026 1121044613 CMS
Galderma Laboratories, L.P. $18.93 09/17/2024 Food and Beverage Undisputed 01/23/2026 1145318346 CMS
GENZYME CORPORATION $24.68 07/10/2024 Food and Beverage Undisputed 01/23/2026 1139585218 CMS
GENZYME CORPORATION $25.06 10/02/2024 Food and Beverage Undisputed 01/23/2026 1139585234 CMS
Janssen Biotech, Inc. $7.13 02/22/2024 Food and Beverage Undisputed 01/23/2026 1078542186 CMS
Janssen Biotech, Inc. $13.83 03/18/2024 Food and Beverage Undisputed 01/23/2026 1078541925 CMS
Janssen Biotech, Inc. $72.00 03/18/2024 Education Undisputed 01/23/2026 1078542031 CMS
Janssen Biotech, Inc. $6.36 04/30/2024 Food and Beverage Undisputed 01/23/2026 1078542076 CMS
Janssen Biotech, Inc. $21.57 06/11/2024 Food and Beverage Undisputed 01/23/2026 1078542221 CMS
Janssen Biotech, Inc. $4.79 07/22/2024 Food and Beverage Undisputed 01/23/2026 1078542100 CMS
Janssen Biotech, Inc. $15.52 08/07/2024 Food and Beverage Undisputed 01/23/2026 1078541945 CMS
Janssen Biotech, Inc. $20.01 12/09/2024 Food and Beverage Undisputed 01/23/2026 1078542263 CMS
Lilly USA, LLC $24.03 02/09/2024 Food and Beverage Undisputed 01/23/2026 1136162557 CMS
Lilly USA, LLC $13.60 04/09/2024 Food and Beverage Undisputed 01/23/2026 1136143791 CMS
Lilly USA, LLC $17.07 05/20/2024 Food and Beverage Undisputed 01/23/2026 1136172880 CMS
Lilly USA, LLC $23.11 08/12/2024 Food and Beverage Undisputed 01/23/2026 1136162237 CMS
Lilly USA, LLC $14.90 11/04/2024 Food and Beverage Undisputed 01/23/2026 1136172882 CMS
Regeneron Healthcare Solutions, Inc. $33.85 02/14/2024 Food and Beverage Undisputed 01/23/2026 1114122883 CMS
Regeneron Healthcare Solutions, Inc. $25.65 05/22/2024 Food and Beverage Undisputed 01/23/2026 1114122885 CMS
Regeneron Healthcare Solutions, Inc. $39.12 07/30/2024 Food and Beverage Undisputed 01/23/2026 1114122887 CMS
Regeneron Healthcare Solutions, Inc. $23.22 12/04/2024 Food and Beverage Undisputed 01/23/2026 1114122889 CMS
UCB, Inc. $37.32 03/21/2024 Food and Beverage Undisputed 01/23/2026 1143358793 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.